EMTRICITABINE\TENOFOVIR DISOPROXIL for Maternal exposure timing unspecified: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 333 adverse event reports in the FDA FAERS database where EMTRICITABINE\TENOFOVIR DISOPROXIL was used for Maternal exposure timing unspecified.
Most Reported Side Effects for EMTRICITABINE\TENOFOVIR DISOPROXIL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Bone density decreased | 16,315 | 41.5% | 191 | 854 |
| Chronic kidney disease | 10,248 | 26.0% | 281 | 1,181 |
| Bone loss | 8,967 | 22.8% | 113 | 469 |
| Osteonecrosis | 8,935 | 22.7% | 116 | 514 |
| Renal failure | 8,618 | 21.9% | 314 | 1,180 |
| Multiple fractures | 8,088 | 20.6% | 123 | 504 |
| Renal injury | 8,000 | 20.3% | 153 | 451 |
| Tooth loss | 7,981 | 20.3% | 74 | 429 |
| Osteoporosis | 7,436 | 18.9% | 86 | 515 |
| Skeletal injury | 7,161 | 18.2% | 155 | 430 |
| Pain | 6,480 | 16.5% | 119 | 752 |
| Emotional distress | 6,320 | 16.1% | 121 | 737 |
| Anxiety | 5,801 | 14.7% | 106 | 704 |
| Anhedonia | 5,589 | 14.2% | 104 | 660 |
| Osteopenia | 3,892 | 9.9% | 22 | 282 |
Other Indications for EMTRICITABINE\TENOFOVIR DISOPROXIL
Hiv infection (27,672)
Prophylaxis against hiv infection (5,005)
Product used for unknown indication (3,799)
Acquired immunodeficiency syndrome (711)
Hepatitis b (301)
Antiretroviral therapy (287)
Prophylaxis (160)
Hiv test positive (102)
Foetal exposure during pregnancy (61)
Hepatitis c (56)
Other Drugs Used for Maternal exposure timing unspecified
VALPROATE (1,477)
ADALIMUMAB (1,280)
NATALIZUMAB (492)
RITONAVIR (486)
LOPINAVIR\RITONAVIR (278)
DIVALPROEX (254)
INTERFERON BETA-1A (245)
DIMETHYL (212)
ATAZANAVIR (169)
DARUNAVIR ETHANOLATE (154)